Stay updated with breaking news from Safety Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FASENRA enabled patients to taper off oral corticosteroids while preventing relapses ...
23.02.2024 - Positive results from the MANDARA Phase III trial for FASENRA (benralizumab) in patients with EGPA were published in the New England Journal of Medicine today,1 as the first head-to-head trial of biologics in patients with EGPA,2 and the first to ...
Results demonstrate rapid and sustained suppression of free TL1A, confirming target engagement of anti-TL1A 1 Anti-TL1A was shown to be safe and well-tolerated, with a low incidence of antidrug...
/PRNewswire/ -- SightGlass Vision, a joint venture of CooperCompanies and EssilorLuxottica that develops innovative technologies and science-based treatments...
SightGlass Vision, a joint venture of CooperCompanies and EssilorLuxottica that develops innovative technologies and science-based treatments to address the global myopia epidemic, today announced that the U.S. Food and Drug Administration (FDA) has...